Iovance Biotherapeutics (IOVA) News Today $1.91 +0.08 (+4.37%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why is Iovance Biotherapeutics Up Today?Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) shares have come under pressure as a wave of securities class actions and investor alerts has been filed against the company, while one institutional investor has added to its stake. Legal filings: Over a dozen law firms—including Levi & Korsinsky, Scott+Scott, Rosen, Bleichmar Fonti & Auld, Pomerantz, Bronstein Gewirtz & Grossman, The Gross Law Firm, Kahn Swick & Foti and others—have announced or filed suits alleging securities law violations during a class period from May 9, 2024 to May 8, 2025. Allegations: Plaintiffs claim Iovance misled investors about trial results or business prospects, contributing to a roughly 44% share decline that triggered the litigation. Deadlines: Investors who suffered losses are being urged to file lead plaintiff motions or join the class action by July 14, 2025, creating an overhang of potential liability. Institutional buying: Man Group plc disclosed in an SEC filing that it acquired approximately 2.4 million IOVA shares in Q4, signaling some confidence from a large asset manager despite the legal cloud. While the fresh stake reported by Man Group offers some offset, the proliferation of class action notices and the looming litigation deadline remain the key factors weighing on IOVA’s stock performance.Posted 4h agoAI generated IOVA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC Continues Lead Plaintiff Search for Iovance Biotherapeutics, Inc. (IOVA) Securities Fraud Class ActionMay 20 at 9:24 PM | globenewswire.comDown More Than 75% This Year, Should Investors Throw in the Towel on Iovance Biotherapeutics Stock?May 20 at 9:10 PM | fool.comScott+Scott Attorneys at Law LLP Alerts Investors of The Pending Class Action Against Iovance Biotherapeutics, Inc. (IOVA)May 20 at 5:17 PM | investing.comDeadline Approaching: Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Urged To Contact Law Offices of Howard G. SmithMay 20 at 12:00 PM | businesswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVAMay 20 at 9:00 AM | prnewswire.comIovance Biotherapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before July 14, 2025 to Discuss Your Rights - IOVAMay 20 at 5:45 AM | prnewswire.comIOVA CLASS ACTION NOTICE: Iovance Biotherapeutics, Inc. ...May 19 at 5:25 PM | gurufocus.comIOVA CLASS ACTION NOTICE: Iovance Biotherapeutics, Inc. has been Sued for Securities Fraud after 44% Stock Drop – Contact BFA Law if You Suffered Losses (NASDAQ:IOVA)May 19 at 4:50 PM | globenewswire.comClass Action Filed Against Iovance Biotherapeutics, Inc. ...May 19 at 4:22 PM | gurufocus.comIOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Iovance Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitMay 19 at 4:00 PM | prnewswire.comClass Action Filed Against Iovance Biotherapeutics, Inc. (IOVA) Seeking Recovery for Investors - Contact The Gross Law FirmMay 19 at 3:01 PM | prnewswire.comIOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud LawsuitMay 19 at 2:31 PM | gurufocus.comDeadline Alert: Iovance Biotherapeutics, Inc. ...May 19 at 2:31 PM | gurufocus.comLaw Offices of Frank R. Cruz Encourages Iovance Biotherapeutics, Inc. ...May 19 at 2:31 PM | gurufocus.comJuly 14, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against IOVAMay 19 at 1:31 PM | globenewswire.comLaw Offices of Frank R. Cruz Encourages Iovance Biotherapeutics, Inc. (IOVA) Investors To Inquire About Securities Fraud Class ActionMay 19 at 12:06 PM | businesswire.comIOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud LawsuitMay 19 at 11:25 AM | prnewswire.comMan Group plc Acquires New Holdings in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)Man Group plc acquired a new stake in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 2,414,996 shares of the biotechnology company's sMay 19 at 5:18 AM | marketbeat.comROSEN, NATIONAL INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IOVAMay 18 at 11:03 PM | globenewswire.comIOVA Investors Have the Opportunity to Lead the Iovance Securities Fraud Lawsuit with Faruqi & Faruqi, LLPMay 18 at 9:04 AM | globenewswire.comIovance Biotherapeutics (NASDAQ:IOVA) Stock Rating Lowered by UBS GroupMay 18 at 1:43 AM | americanbankingnews.comIovance downgraded to Neutral at UBS on Amtagvi concernsMay 17, 2025 | seekingalpha.comIovance Biotherapeutics (NasdaqGM:IOVA) Faces Legal Action Amid Revenue Guidance CutMay 17, 2025 | finance.yahoo.comIovance Shareholders Should Contact Shareholder Rights Firm Regarding Potential Legal ClaimsMay 17, 2025 | prnewswire.comIovance Biotherapeutics, Inc. (NASDAQ:IOVA) Shares Acquired by Ensign Peak Advisors IncEnsign Peak Advisors Inc increased its position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA - Free Report) by 673.9% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 577,265 shares of the biotechnology company's stock after purchasingMay 17, 2025 | marketbeat.comUBS Downgrades Iovance Biotherapeutics (IOVA)May 17, 2025 | msn.comIovance downgraded to Neutral at UBS related to Amtagvi concernsMay 17, 2025 | msn.comIOVA Shareholder Alert: Robbins LLP Informs Investors of the Iovance Biotherapeutics, Inc. Class Action LawsuitMay 16, 2025 | prnewswire.comFORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues Lead Plaintiff Search for Iovance Biotherapeutics, Inc. (IOVA) Securities Fraud Class ActionMay 16, 2025 | businesswire.comIOVANCE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Iovance Biotherapeutics, Inc. and Encourages Investors to Contact the FirmMay 16, 2025 | globenewswire.comGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Iovance Biotherapeutics, Inc. (IOVA)May 16, 2025 | globenewswire.comWhy Iovance Biotherapeutics Tumbled by Nearly 6% TodayMay 16, 2025 | fool.comIovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)May 16, 2025 | globenewswire.comIOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Iovance Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitMay 16, 2025 | globenewswire.comLaw Offices of Howard G. Smith Encourages Iovance Biotherapeutics, Inc. (IOVA) Investors to Inquire About Securities Fraud Class ActionMay 16, 2025 | businesswire.comRosen Law Firm Urges Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) Stockholders With Large Losses to Contact the Firm for Information About Their RightsMay 16, 2025 | businesswire.comINVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Iovance Biotherapeutics, Inc. (IOVA) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the FirmMay 16, 2025 | globenewswire.comMPM Bioimpact LLC Has $19.79 Million Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)MPM Bioimpact LLC boosted its holdings in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA - Free Report) by 11.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,673,905 shares of the biotechnology company's stock after acquiriMay 16, 2025 | marketbeat.comNorthern Trust Corp Increases Stock Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)Northern Trust Corp grew its position in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA - Free Report) by 7.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,414,807 shares of the biotechnology compMay 16, 2025 | marketbeat.comIovance Biotherapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - IOVAMay 16, 2025 | tmcnet.comIOVA CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Iovance Biotherapeutics, Inc.May 16, 2025 | businesswire.comIOVA CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit On Behalf Of Iovance Biotherapeutics, Inc. InvestorsMay 16, 2025 | businesswire.comSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Iovance Biotherapeutics, Inc. Securities and Sets a Lead Plaintiff Deadline of July 14, 2025May 15, 2025 | globenewswire.comIovance Biotherapeutics (NASDAQ:IOVA) Stock Price Down 5.4% Following Analyst DowngradeIovance Biotherapeutics (NASDAQ:IOVA) Trading Down 5.4% After Analyst DowngradeMay 15, 2025 | marketbeat.comIs This Beaten-Down Stock a Buy Near Its 52-Week Low?May 15, 2025 | fool.comIovance Biotherapeutics' (IOVA) Annual Maintenance: Assurances Collide with Adverse Disclosure as Shares Plunge 44% – Hagens BermanMay 14, 2025 | globenewswire.comIovance Biotherapeutics (NASDAQ:IOVA) Sees Strong Trading Volume - What's Next?Iovance Biotherapeutics (NASDAQ:IOVA) Sees Unusually-High Trading Volume - Here's WhyMay 14, 2025 | marketbeat.comIovance Biotherapeutics (NASDAQ:IOVA) Given New $8.00 Price Target at The Goldman Sachs GroupThe Goldman Sachs Group lowered their price objective on shares of Iovance Biotherapeutics from $16.00 to $8.00 and set a "buy" rating for the company in a research note on Monday.May 14, 2025 | marketbeat.comMizuho Lowers Iovance Biotherapeutics (NASDAQ:IOVA) Price Target to $10.00Mizuho dropped their target price on Iovance Biotherapeutics from $30.00 to $10.00 and set an "outperform" rating on the stock in a research report on Monday.May 14, 2025 | marketbeat.comBarclays Lowers Iovance Biotherapeutics (NASDAQ:IOVA) Price Target to $4.00Barclays lowered their price target on Iovance Biotherapeutics from $5.00 to $4.00 and set an "overweight" rating for the company in a report on Monday.May 14, 2025 | marketbeat.com Get Iovance Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for IOVA and its competitors with MarketBeat's FREE daily newsletter. Email Address IOVA Media Mentions By Week IOVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IOVA News Sentiment▼0.080.65▲Average Medical News Sentiment IOVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IOVA Articles This Week▼578▲IOVA Articles Average Week Get Iovance Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for IOVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Xenon Pharmaceuticals News Today Amneal Pharmaceuticals News Today Organon & Co. News Today HUTCHMED News Today Mirum Pharmaceuticals News Today Apellis Pharmaceuticals News Today Arrowhead Pharmaceuticals News Today Vericel News Today NewAmsterdam Pharma News Today Ascentage Pharma Group International News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IOVA) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iovance Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Iovance Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IOVA Stock Free IOVA Stock Alerts